Carteret Health Care is a 135-bed, non-profit hospital in Morehead City, North Carolina. Carteret General was founded in 1967.

During the past decade, Carteret Health Care Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carteret Health Care Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carteret Health Care Cancer Center" are "Carcinoma" (1 trials), "Chronic Myeloproliferative Disorders" (1 trials), "Cognitive/Functional Effects" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Carteret Health Care Cancer Center" in a lesser frequency.

Most popular intervention types in "Carteret Health Care Cancer Center" are "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Financial Navigation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carteret Health Care Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Carteret Health Care Cancer Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Carteret Health Care Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carteret Health Care Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".